4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-050002
Director bought 57,100 shares at an average $104.43 ($5,963,124)
From the SEC's structured data for this filing
Trades in this filing
Chambers Michael Andrew · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-14 | Purchase : show line 1 in the form | +20,744 | $103.87 | $2,154,679 | 71,822 | D |
| 2022-09-14 | Purchase : show line 2 in the form | +30,106 | $104.67 | $3,151,195 | 101,928 | D |
| 2022-09-14 | Purchase : show line 3 in the form | +6,250 | $105.16 | $657,250 | 108,178 | D |
| Open-market purchases · 57,100 sh · avg $104.43 · $5,963,124 | ||||||
Loading xslF345X03/doc4.xml…